These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38433569)

  • 21. [Clinical application of LDLT after reconstruction of IVC using artificial blood vessel in the treatment of HCC beyond Milan Criteria].
    Sun BC; Li GQ; Huang XL; Qin JJ; Mu XX
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):211-215. PubMed ID: 29575841
    [No Abstract]   [Full Text] [Related]  

  • 22. Current role of liver transplantation for methylmalonic acidemia: a review of the literature.
    Kasahara M; Horikawa R; Tagawa M; Uemoto S; Yokoyama S; Shibata Y; Kawano T; Kuroda T; Honna T; Tanaka K; Saeki M
    Pediatr Transplant; 2006 Dec; 10(8):943-7. PubMed ID: 17096763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort.
    Kulik LM; Fisher RA; Rodrigo DR; Brown RS; Freise CE; Shaked A; Everhart JE; Everson GT; Hong JC; Hayashi PH; Berg CL; Lok AS;
    Am J Transplant; 2012 Nov; 12(11):2997-3007. PubMed ID: 22994906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Living-donor liver transplantation for hepatocellular carcinoma.
    Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
    Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma.
    Ninomiya M; Shirabe K; Facciuto ME; Schwartz ME; Florman SS; Yoshizumi T; Harimoto N; Ikegami T; Uchiyama H; Maehara Y
    J Am Coll Surg; 2015 Mar; 220(3):297-304.e3. PubMed ID: 25617912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence.
    Sandhu L; Sandroussi C; Guba M; Selzner M; Ghanekar A; Cattral MS; McGilvray ID; Levy G; Greig PD; Renner EL; Grant DR
    Liver Transpl; 2012 Mar; 18(3):315-22. PubMed ID: 22140013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.
    Xiao GQ; Song JL; Shen S; Yang JY; Yan LN
    World J Gastroenterol; 2014 Aug; 20(31):10953-9. PubMed ID: 25152599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma.
    Lo CM; Fan ST; Liu CL; Chan SC; Ng IO; Wong J
    Br J Surg; 2007 Jan; 94(1):78-86. PubMed ID: 17016793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation.
    Di Sandro S; Slim AO; Giacomoni A; Lauterio A; Mangoni I; Aseni P; Pirotta V; Aldumour A; Mihaylov P; De Carlis L
    Transplant Proc; 2009 May; 41(4):1283-5. PubMed ID: 19460539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease.
    Brassier A; Boyer O; Valayannopoulos V; Ottolenghi C; Krug P; Cosson MA; Touati G; Arnoux JB; Barbier V; Bahi-Buisson N; Desguerre I; Charbit M; Benoist JF; Dupic L; Aigrain Y; Blanc T; Salomon R; Rabier D; Guest G; de Lonlay P; Niaudet P
    Mol Genet Metab; 2013; 110(1-2):106-10. PubMed ID: 23751327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Living or Brain-dead Donor Liver Transplantation for Hepatocellular Carcinoma: A Multicenter, Western, Intent-to-treat Cohort Study.
    Azoulay D; Audureau E; Bhangui P; Belghiti J; Boillot O; Andreani P; Castaing D; Cherqui D; Irtan S; Calmus Y; Chazouillères O; Soubrane O; Luciani A; Feray C
    Ann Surg; 2017 Dec; 266(6):1035-1044. PubMed ID: 27617853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pure Laparoscopic Living Donor Right Hepatectomy Using Real-Time Indocyanine Green Fluorescence Imaging.
    Kim YS; Choi SH
    J Gastrointest Surg; 2019 Aug; 23(8):1711-1712. PubMed ID: 31152351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Successful adult domino living donor liver transplantation in methylmalonic acidemia: case report.
    Chorley AJ; Terkivatan T; de Jonge J; Polak WG; Tran KTC; Unkhoff C; den Hoed CM; Wagenmakers MAEM; Ijzermans JNM; Minnee RC; Boehnert MU
    Transl Gastroenterol Hepatol; 2024; 9():12. PubMed ID: 38317745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation.
    Morita K; Taketomi A; Soejima Y; Ikegami T; Fukuhara T; Iguchi T; Nagata S; Sugimachi K; Gion T; Shirabe K; Maehara Y
    Liver Transpl; 2009 Nov; 15(11):1412-6. PubMed ID: 19877253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation.
    Kim SH; Lee EC; Na BG; Park SJ
    Eur J Surg Oncol; 2019 Feb; 45(2):180-186. PubMed ID: 30243467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive combined resection of hepatic inferior vena cava, with replacement by a ringed expanded polytetrafluoroethylene graft, in living-donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Matsuda H; Sadamori H; Shinoura S; Umeda Y; Yoshida R; Satoh D; Utsumi M; Onishi T; Yagi T
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):719-24. PubMed ID: 20425126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Kim JM; Kwon CHD; Joh JW; Han S; Yoo J; Kim K; Sinn DH; Choi GS; Gerber DA; Egawa H; Lee SK
    Transplantation; 2018 Oct; 102(10):1695-1701. PubMed ID: 29494419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.